Acute myeloblastic leukemia, not having achieved remission is a hematological malignancy characterized by the rapid proliferation of myeloblasts in the bone marrow and peripheral blood. This condition is clinically significant due to its aggressive nature and poor prognosis if left untreated. The ICD-10 Code C92.00 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this serious condition.
ICD-10 Code C92.00 represents Acute myeloblastic leukemia that has not achieved remission. This code is used when a patient presents with symptoms and laboratory findings indicative of acute myeloblastic leukemia, and there is no evidence of remission following treatment. It is essential for clinical documentation and billing to accurately reflect the severity and ongoing nature of the disease.
Acute myeloblastic leukemia, not having achieved remission, is caused by genetic mutations leading to the uncontrolled proliferation of myeloid progenitor cells. The disease progresses rapidly, often resulting in severe anemia, thrombocytopenia, and increased susceptibility to infections. Immediate medical attention is crucial for management and treatment.
ICD-10 Code C92.00 is utilized in SOAP notes to document the patient's symptoms, assessment, and treatment plan. It is relevant in both acute and chronic care settings, ensuring that the severity of the condition is accurately captured for ongoing management and billing purposes.
In SOAP notes, ICD-10 Code C92.00 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of acute myeloblastic leukemia, not having achieved remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of Acute myeloblastic leukemia, not having achieved remission requires urgent intervention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C92.00 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85027 | Complete blood count with differential. |
| 85041 | Blood count, automated, with manual differential. |
| 36415 | Collection of venous blood by venipuncture. |
| 88305 | Pathology examination of tissue, including bone marrow biopsy. |
Common Questions About Using ICD-10 Code C92.00 for Acute myeloblastic leukemia, not having achieved remission
What are the common symptoms of Acute myeloblastic leukemia?
Common symptoms include fatigue, fever, easy bruising or bleeding, and frequent infections due to low blood cell counts. Patients may also experience weight loss and night sweats.
How is Acute myeloblastic leukemia diagnosed?
Diagnosis is typically made through a combination of blood tests, bone marrow biopsy, and cytogenetic analysis to identify specific genetic mutations associated with the disease.
What treatment options are available for Acute myeloblastic leukemia?
Treatment usually involves chemotherapy, targeted therapy, and supportive care such as blood transfusions and antibiotics to manage infections and complications.
How does ICD-10 Code C92.00 affect billing?
ICD-10 Code C92.00 is essential for accurate billing as it reflects the severity of the patient's condition, ensuring appropriate reimbursement for the services provided in acute care settings.
Clinical Notes
SOAP notes
DAP notes
AI medical notes